A blockchain-driven architecture for antimicrobial resistance detection

Alexe Luca Spataru

Antibiotics are essential tools for modern-day medical activities, from treating minor infections to enabling complicated surgeries or organ transplants. However, the efficiency of antibiotics, and other antimicrobial products, is put at risk when microbial agents develop resistance, which can lead to not finding any alternative means of treatment. A major cause for the development of resistance in pathogens is the misuse, overuse, and use without a prescription of antimicrobials. This presentation discusses some innovative approaches of applying a blockchain architecture for preventing and detecting antimicrobial resistance through certifying the trusted actors in the ecosystem, as well as enabling reliable methods for receipt prescription and surveilling consumption.